Characteristics of Patients With Long COVID, Persistent Impaired Sense of Smell

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, SEPTEMBER 8, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.30637?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=090822

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: In this study of 219 patients with long COVID and neurologic symptoms, 64% had an impaired sense of smell, with the highest prevalence among women, adults, and those not hospitalized during the acute phase of COVID-19. Patients with an impaired sense of smell may develop severe loss of smell that may persist for more than 1 year after the onset of symptoms.

Authors: Luiz Fabio Magno Falcao, Ph.D., of Para State University in Belem, Brazil, is the corresponding author.

  

(doi:10.1001/jamanetworkopen.2022.30637)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.